[MeS01] メディカルセミナー 1　Treatment Strategies in HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer. Focusing on 3rd or Later-line Setting based on the DESTINY-Gastric01 Study

[MeS01-1] Treatment strategies for HER2-Positive Advanced Gastric Cancer

^○Min-Hee Ryu (Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KOREA)